Login
Powered by
MOMENTUM
MEDIA
Powered by MOMENTUM MEDIA
A “landmark” agreement has been struck to provide access to Commonwealth-subsidised medicines and support for aged care, among other measures.
Firm: Maddocks (Commonwealth Department of Health).
The agreement also “sets the price that is paid to pharmacists for dispensing medicines under the Pharmaceutical Benefits Scheme, which is expected to be $16 billion in Commonwealth spending over the five-year term of the agreement”, Maddocks said in a statement.
Value: $16 billion in Commonwealth spending over the five-year term of the agreement.
Area: Healthcare, government.
Key players: The Maddocks team was led by partner Andrew Whiteside, who was supported by special counsel Paul Ellis and lawyer Xinyu Zhang.
Deal significance: Maddocks healthcare sector leader Lucille Scomazzon said: “[Maddocks’] work on the 7CPA is another significant achievement for our [healthcare sector] team, showcasing the depth of our expertise in the pharmacy and pharmaceutical sectors. Congratulations Andrew and the team.”
The firm’s Commonwealth government sector leader Simonetta Astolfi added: “The 7CPA is another example of the great work we are doing for Commonwealth [government] clients and its signing is a proud achievement for the firm.”
Jerome Doraisamy is the managing editor of Lawyers Weekly and HR Leader. He is also the author of The Wellness Doctrines book series, an admitted solicitor in New South Wales, and a board director of the Minds Count Foundation.
You can email Jerome at:
Get breaking news
Jerome Doraisamy
